The Molecular Biology of Myeloma
David S. Siegel, MD, PhD
Video Categories: Targeted Therapies
Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
September 20, 2013
Jennifer Malin discusses the aspects of value and how they are realized in personalized medicine
December 12, 2016
Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.